In the Phase 3 LIBRETTO-431 study, Retevmo more than doubled progression-free survival (PFS) compared to chemotherapy plus pembrolizumab in patients with advanced or metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC)
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20
The plant has a capacity for extraction of 2500 mt of poppy straw and 300 mt poppy gum per year
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
